“The extravascular, intrapericardial balloon implant requires no large vessel access, and the system avoids many of the current standard of care complications, such as major bleeding, hemolysis ...

The intravascular hemolysis of the AHTR produces the classic signs of hemoglobinemia and hemoglobinuria, which are pathognomonic of this condition (they may occur in extravascular HTR if very ...

Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...

Hemolytic anemia describes a large group of conditions characterized by accelerated destruction of red blood cells. The average lifespan of a red blood cell is 120 days. At the end of 120 days, the ...

Transitioning from vemircopan to ravulizumab can lead to severe extravascular hemolysis in patients with PNH. The treatment of paroxysmal nocturnal hemoglobinuria (PNH) is advancing with proximal ...

PNH is characterized by episodic hemolysis, thrombosis, and bone marrow failure. In March 2024, the US Food and Drug Administration (FDA) granted approval for danicopan (a complement factor D ...